Found: 88
Select item for more details and to access through your institution.
T-Cell Subsets and Their Cytokine Profiles in Transplantation and Tolerance.
- Published in:
- Annals of the New York Academy of Sciences, 1995, v. 770, n. 1, p. 141, doi. 10.1111/j.1749-6632.1995.tb31051.x
- By:
- Publication type:
- Article
Comment on M. Guillot-Delost et al. (2008;10:834-846): Clinical-grade preparation of human natural regulatory T cells encoding the thymidine kinase suicide gene as a safety gene.
- Published in:
- Journal of Gene Medicine, 2009, v. 11, n. 2, p. 180, doi. 10.1002/jgm.1286
- By:
- Publication type:
- Article
In vivo neutralization of inflammatory cytokines might not be necessary for regulatory T-cell immunotherapy.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans.
- Published in:
- Nature Reviews Immunology, 2007, v. 7, n. 8, p. 585, doi. 10.1038/nri2138
- By:
- Publication type:
- Article
Type 1 regulatory T cellmediated tolerance in health and disease.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1032575
- By:
- Publication type:
- Article
The Women of FOCIS: Promoting Equality and Inclusiveness in a Professional Federation of Clinical Immunology Societies.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.816535
- By:
- Publication type:
- Article
Hergen Spits—A legend at the top of his career.
- Published in:
- Allergy, 2021, v. 76, n. 6, p. 1925, doi. 10.1111/all.14788
- By:
- Publication type:
- Article
Human‐engineered Treg‐like cells suppress FOXP3‐deficient T cells but preserve adaptive immune responses in vivo.
- Published in:
- Clinical & Translational Immunology, 2020, v. 9, n. 11, p. 1, doi. 10.1002/cti2.1214
- By:
- Publication type:
- Article
InsB9-23 Gene Transfer to Hepatocyte-Based Combined Therapy Abrogates Recurrence of Type 1 Diabetes After Islet Transplantation.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Antigen-Specific Dependence of Tr1-Cell Therapy in Preclinical Models of Islet Transplant.
- Published in:
- Diabetes, 2010, v. 59, n. 2, p. 433, doi. 10.2337/db09-1168
- By:
- Publication type:
- Article
Rapamycin prevents and breaks the anti-CD3-induced tolerance in NOD mice.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Rapamycin Prevents and Breaks the Anti-CD3--Induced Tolerance in NOD Mice.
- Published in:
- Diabetes, 2009, v. 58, n. 4, p. 875, doi. 10.2337/db08-1432
- By:
- Publication type:
- Article
Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Rapamycin Monotherapy in Patients With Type 1 Diabetes Modifies CD4<sup>+</sup>CD25<sup>+</sup>FOXP3<sup>+</sup> Regulatory T-Cells.
- Published in:
- Diabetes, 2008, v. 57, n. 9, p. 2341, doi. 10.2337/db08-0138
- By:
- Publication type:
- Article
Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Induction of Tolerance in Type 1 Diabetes via Both CD4<sup>+</sup>CD25<sup>+</sup> T Regulatory Cells and T Regulatory Type 1 Cells.
- Published in:
- Diabetes, 2006, v. 55, n. 6, p. 1571, doi. 10.2337/db05-1576
- By:
- Publication type:
- Article
Rapamycin and Interleukin-10 Treatment Induces T Regulatory Type 1 Cells That Mediate Antigen-Specific Transplantation Tolerance.
- Published in:
- Diabetes, 2006, v. 55, n. 1, p. 40, doi. 10.2337/diabetes.55.01.06.db05-0613
- By:
- Publication type:
- Article
Engineered T Regulatory Type 1 Cells for Clinical Application.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00233
- By:
- Publication type:
- Article
First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00113
- By:
- Publication type:
- Article
Gene therapy for ADA-SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products.
- Published in:
- EMBO Molecular Medicine, 2017, v. 9, n. 6, p. 737, doi. 10.15252/emmm.201707573
- By:
- Publication type:
- Article
Reappraisal of in utero Stem Cell Transplantation Based on Long-Term Results.
- Published in:
- Fetal Diagnosis & Therapy, 2004, v. 19, n. 4, p. 305, doi. 10.1159/000077957
- By:
- Publication type:
- Article
Enforced IL-10 Expression Confers Type 1 Regulatory T Cell (Tr1) Phenotype and Function to Human CD4<sup>+</sup> T Cells.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 9, p. 1778, doi. 10.1038/mt.2012.71
- By:
- Publication type:
- Article
Corrigendum to “Evidence for Long-term Efficacy and Safety of Gene Therapy for Wiskott–Aldrich Syndrome in Preclinical Models”.
- Published in:
- 2009
- By:
- Publication type:
- Correction notice
Evidence for Long-term Efficacy and Safety of Gene Therapy for Wiskott–Aldrich Syndrome in Preclinical Models.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 6, p. 1073, doi. 10.1038/mt.2009.31
- By:
- Publication type:
- Article
Generation of Potent and Stable Human CD4<sup>+</sup> T Regulatory Cells by Activation-independent Expression of FOXP3.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 1, p. 194, doi. 10.1038/sj.mt.6300341
- By:
- Publication type:
- Article
981. Prevention of Transgene Expression in Antigen Presenting Cells Correlate with Modulated Immune Response after In Vivo Gene Transfer.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S377, doi. 10.1016/j.ymthe.2006.08.1074
- By:
- Publication type:
- Article
65. Long-Term Effects of Hematopoietic Stem Cell Gene Therapy in the Murine Model of Wiskott-Aldrich Syndrome: Persistence of Functional Correction of T Cells and Lack of Malignant Trasformation.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S27, doi. 10.1016/j.ymthe.2006.08.081
- By:
- Publication type:
- Article
79. Systemic Administration of Lentiviral Vectors Triggers Innate Host Responses.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S33, doi. 10.1016/j.ymthe.2006.08.096
- By:
- Publication type:
- Article
672. Lentiviral Vectors Targeting WASp Expression to Hematopoietic Cells, Efficiently Transduce CD34+ Cells and Correct Functions of Lymphocytes and Dendritic Cells from Wiskott-Aldrich Syndrome Patients.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S259, doi. 10.1016/j.ymthe.2006.08.749
- By:
- Publication type:
- Article
468. Cellular Therapy with Transgene Expressing APC Activates CD4 + CD25+ Regulatory T Cells Which Modulate the Immune Response to Gene Therapy Derived Products in Immunocompetent Mice
- Published in:
- 2005
- By:
- Publication type:
- Abstract
345. Gene Therapy for Wiskott-Aldrich Syndrome Using Lentiviral Vectors: Evidence for Efficacy and Safety after Transduction of Human T Cells and Hematopoietic Stem Cells
- Published in:
- 2005
- By:
- Publication type:
- Abstract
331. Lentivirus-Mediated Ex Vivo Gene Therapy in ADA-Deficient SCID Mice
- Published in:
- 2005
- By:
- Publication type:
- Abstract
330. Lentiviral Vector Mediated Hematopoietic Stem Cell Gene Therapy Combined with Non-Lethal Conditioning Restores T Cell Function in the Murine Model of Wiskott-Aldrich Syndrome
- Published in:
- 2005
- By:
- Publication type:
- Abstract
36. Improved Lentiviral Vectors for Systemic Gene Transfer in the Absence of an Immune Response
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Erratum to “Lentiviral Vector-Mediated Gene Transfer in T Cells from Wiskott–Aldrich Syndrome Patients Leads to Functional Correction”
- Published in:
- 2005
- By:
- Publication type:
- Correction notice
IL-3 or IL-7 Increases ex Vivo Gene Transfer Efficiency in ADA-SCID BM CD34<sup>+</sup> Cells while Maintaining in Vivo Lymphoid Potential
- Published in:
- Molecular Therapy, 2004, v. 10, n. 6, p. 1096, doi. 10.1016/j.ymthe.2004.08.014
- By:
- Publication type:
- Article
Lentiviral Vector-Mediated Gene Transfer in T Cells from Wiskott–Aldrich Syndrome Patients Leads to Functional Correction
- Published in:
- Molecular Therapy, 2004, v. 10, n. 5, p. 903, doi. 10.1016/j.ymthe.2004.08.008
- By:
- Publication type:
- Article
Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Gene correction for SCID-X1 in long-term hematopoietic stem cells.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-09614-y
- By:
- Publication type:
- Article
From IPEX syndrome to <italic>FOXP3</italic> mutation: a lesson on immune dysregulation.
- Published in:
- Annals of the New York Academy of Sciences, 2018, v. 1417, n. 1, p. 5, doi. 10.1111/nyas.13011
- By:
- Publication type:
- Article
Clinical Outlook for Type-1 and FOXP3<sup>+</sup> T Regulatory Cell-Based Therapy.
- Published in:
- Frontiers in Immunology, 2015, v. 6, p. 1, doi. 10.3389/fimmu.2015.00593
- By:
- Publication type:
- Article
Immunological outcome in haploidentical-HSC transplanted patients treated with IL-10-anergized donor T Cells.
- Published in:
- Frontiers in Immunology, 2014, v. 4, p. 1, doi. 10.3389/fimmu.2014.00016
- By:
- Publication type:
- Article
Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells.
- Published in:
- European Journal of Immunology, 2011, v. 41, n. 6, p. 1652, doi. 10.1002/eji.201041120
- By:
- Publication type:
- Article
Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naïve T cells.
- Published in:
- European Journal of Immunology, 2010, v. 40, n. 11, p. 3097, doi. 10.1002/eji.201040659
- By:
- Publication type:
- Article
The Tregs' world according to GARP.
- Published in:
- European Journal of Immunology, 2009, v. 39, n. 12, p. 3296, doi. 10.1002/eji.200940117
- By:
- Publication type:
- Article
Is FOXP3 a bona fide marker for human regulatory T cells?
- Published in:
- European Journal of Immunology, 2008, v. 38, n. 4, p. 925, doi. 10.1002/eji.200838168
- By:
- Publication type:
- Article
Liver gene therapy by lentiviral vectors reverses anti-factor IX pre-existing immunity in haemophilic mice.
- Published in:
- EMBO Molecular Medicine, 2013, v. 5, n. 11, p. 1684, doi. 10.1002/emmm.201302857
- By:
- Publication type:
- Article
Integration profile of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cell.
- Published in:
- EMBO Molecular Medicine, 2011, v. 3, n. 2, p. 89, doi. 10.1002/emmm.201000108
- By:
- Publication type:
- Article
Correction of β-thalassemia major by gene transfer in haematopoietic progenitors of pediatric patients.
- Published in:
- EMBO Molecular Medicine, 2010, v. 2, n. 8, p. 315, doi. 10.1002/emmm.201000083
- By:
- Publication type:
- Article
Rapamycin Combined with Anti-CD45RB mAb and IL-10 or with G-CSF Induces Tolerance in a Stringent Mouse Model of Islet Transplantation.
- Published in:
- PLoS ONE, 2011, v. 6, n. 12, p. 1, doi. 10.1371/journal.pone.0028434
- By:
- Publication type:
- Article